Opportunities. Shift in Perspective for Infectious Disease Control (Porter et al 1999 Health Policy and Planning 14: 322-328) From: Disease specificity.

Slides:



Advertisements
Similar presentations
Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.
Advertisements

Climate change and health research 1 |1 | Priorities for climate change and health research Maria Neira, Director Public Health and Environment Department.
UNDP RBA MDG-Based National Planning Workshop
Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
1. 2 Why are Result & Impact Indicators Needed? To better understand the positive/negative results of EC aid. The main questions are: 1.What change is.
1. 2 Why are Result & Impact Indicators Needed? To better understand the positive/negative results of EC aid. The main questions are: 1.What change is.
Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July Ties Boerma HIV Department Surveillance,
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Malaria Figures 3.3 billion people at risk of malaria in billion at high risk (>1 case/1000 population) mainly in the WHO African (49%) and South.
The relative importance of DOTS. DOTS Strategy 2005 Prevention starts with cure : New STOP TB Strategy -Development of new medical technologies.
Our vision is a world free from TB. Our mission is to address the health, social and economic impact of the global TB epidemic amongst vulnerable and.
The Effectiveness of Global Health Partnerships Findings and Lessons from a World Bank Evaluation of Global Health Programs Uma Lele April 14, 2005.
Unit 1. Introduction TB Infection Control Training for Managers at the National and Subnational Levels.
Global Tuberculosis Burden Philippe Glaziou Cancun, December 2009.
Social inclusion initiatives: the effect of joined up approaches Justine McNamara and Alicia Payne Paper presented at the 11 th Australian Institute of.
Karin Weyer WHO Stop TB Department Stop TB Partnership Global Laboratory Initiative.
EDUCATION FOR ALL – A RIGHT ?
Tuberculosis Control Dr. Yeşim YASİN Fall-2013.
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
Improving diagnosis TB laboratory strengthening.
Trends in TB R&D investment: Where is funding most needed? Lindsey Wu Policy Analyst Policy Cures
Review of Maternal and Child Health Service
The TB situation in the Americas: Reaching the MDGs on TB Dr. Jarbas Barbosa Area Manager, Health Surveillance & Disease Management 23 March 2007.
11-14 Nov 511 Stop TB Challenging for Effective Manager นพ. ศุภกิจ ศิริลักษณ์ พบ., อว., MPHM. ผู้อำนวยการสำนักนโยบายและ ยุทธศาสตร์
Dr. E. Anne Peterson, MD, MPH Assistant Administrator, Bureau for Global Health, USAID Sustainable Investment and Donor Coordination Stop TB Partners Forum.
Tuberculosis in India: A Critical Analysis Lynette Menezes, MSW.
Health Aspect of Disaster Risk Assessment Dr AA Abubakar Department of Community Medicine Ahmadu Bello University Zaria Nigeria.
Monitoring and Evaluation Frameworks Kyiv, Ukraine May 23, 2006 MEASURE Evaluation.
U. S. Senate Briefing World TB Day Celine Gounder, MD, ScM Center for TB Research, Johns Hopkins University Director for Delivery, CREATE On behalf of.
National TB Program Indonesia 1 TB Epidemic DOTS HIV Epidemic.
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
World Health Organization Conference on Developing New SPHs Jerusalem March, 2002 What should an MPH graduate be able to do at the end of the training.
Technical Advisory Group meeting, WHO/WPRO
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Directions in national immigrant health National Symposium on Immigrant Health Citizenship and Immigration Canada Citoyenneté et Immigration Canada Medical.
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
EQUI - TB Knowledge Programme Quality Assured TB Care for Poor People in Resource Constrained settings 2001 – 2006 Purpose: To promote implementation of.
Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
 Critical Enablers for HIV, TB & Malaria Responses UNDP & Global Fund informal session 30 th meeting of the Global Fund Board Dr Mandeep Dhaliwal United.
COUNTRY ACTION: SUSTAINABLE INVESTMENT STOP TB PARTNERSHIP FORUM STOP TB PARTNERSHIP FORUM 24TH-26TH MARCH TH-26TH MARCH 2004 BY BY MRS NENADI USMAN.
Improving TB-DM Care in the Pacific: Partnerships and Progress R. Brostrom, MD-MSPH Hawaii TB Control Branch Chief Regional TB Field Medical Officer, CDC-DTBE.
COSI How can we reach the target to halt the increase of childhood obesity by 2025?
1 African Platform on HRH The Future of the CHW– Lessons from HIV Programs International AIDS Society Pre-conference Bridging the Divide: Interdisciplinary.
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
Epidemiology of tuberculosis. Peymane Adab, Richard Fielding, Susana Castan.
TB and Poverty in The Global Plan to Stop TB Valerie Diaz, Sarah England, Knut Lönnroth, Giorgio Roscigno Stop TB Partnership Stop TB Department,
Our vision: Healthier communities, Excellence in healthcare Our values: Teamwork, Honesty, Respect, Ethical, Excellence, Caring, Commitment, Courage DOTS.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Proposed Post-2015 Global Tuberculosis Strategy and Targets Dr Mario Raviglione Director, Global TB Programme World Health Organization, Geneva, Switzerland.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Policies and strategies to expand ECCE: what makes a difference in countries Input from UNGEI technical meeting.
Global Tuberculosis Control 2007 Did we reach the 2005 targets? Will we achieve the Millennium Development Goals?
American Public Health Association – Annual Meeting 2007 Politics, Policy and Public Health Session : Institutionalizing Tuberculosis Control Strengthening.
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Overview of guidance/frameworks
McKinsey 7s.
Nazir Ismail CTB/NICD & WHO-SRL & UP
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Key issues in DOTS implementation
Vietnam Investment and Finance for TB
From TB control to integrated respiratory disease control
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
The STOP TB Strategy – 2009 VISION: A TB-free world
A Time of Commitments and Actions to accelerate action to End TB
5th edition NTP MANUAL OF PROCEDURES Chapter 1: Introduction
Presentation transcript:

Opportunities

Shift in Perspective for Infectious Disease Control (Porter et al 1999 Health Policy and Planning 14: ) From: Disease specificity and verticality Standardised interventions Short term orientation Emphasis on product/targets To: Integrated/ Horizontal linkages Flexibility/context sensitivity Longer term objectives/sustainability Emphasis on process

Shift in Perspective for Infectious Disease Control (Porter et al 1999 Health Policy and Planning 14: ) From: Limited to health sector Focus on individual risk Operating without reference to global processes Working on behalf of populations To: Linking multiple sectors Understanding social vulnerability: risk in the context of everyday life Taking globalization as referent and context Working in partnership with communities

Tuberculosis Control as an example

Phase 1 Phase 2 Phase 3 Phase 4 Initial effect of segregation of poor consumptives in work house Segregation of poor consumptives in enlarged and improved workhouses infirmaries Systematic segregation of consumptives, rich and poor, In hospitals and sanatoria Antibiotic era Source: data derived from various sources including T. McKewon. The modern rise of population, London: Edward Arnold Year Standardised notification rate Kochs discovery Historical decline of TB,

Source: World Economic Forum, 2005 TB & Poverty overlap

Risk factors for TB Risk factorRelative risk for active TB disease (range) Weighted prevalence, total population Population Attributable Fraction (Range) HIV infection8.3 ( )1.1%7.3% ( ) Malnutrition4.0 ( )17.2%34.1% ( ) Diabetes3.0 ( )3.4%6.3% ( ) Alcohol2.9 ( )3.2%5.7% ( ) Active smoking2.6 ( )18.2%22.7% ( ) Indoor pollution1.5 ( )71.1%26.2% ( ) From Lonnroth K et Al. Global epidemiology of tuberculosis. Seminars in Respiratory and Critical Care Medicine, 3 March 2008

WHO-recommended Global Strategy to Stop TB and reach the targets for Pursuing quality DOTS expansion and enhancement Political commitment Case detection through bacteriology Standardised treatment, with supervision and patient support Effective drug supply system Monitoring system and impact evaluation Additional components 2Addressing TB/HIV and MDR-TB 3. Contributing to health system strengthening 4. Engaging all care providers 5. Empowering patients and communities 6. Enabling and promoting research Stop TB Department

Global TB Control Targets: the theory 2015: 50% reduction in TB prevalence and deaths 2050: elimination (<1 case per million population) 5-10% declining incidence per year: – 70% detection rate – 85% successful treatment

Global TB Control Targets: the reality Case detection rate 61% globally in % in Africa 52% in European/Eastern Mediterranean regions 2/3 of missing cases are in China, India, Africa Treatment success rate 84.6% globally 70% in Eastern Europe 76% in Africa